GRK5-Leu41 allele decreases the activity of βAR signaling in a similar way to a partial blockade of βAR by β-blockers, promoting cardioprotective effects against experimental catecholamine-induced cardiomyopathy. This evidence concerns the gene ADRB2 and cardiomyopathy.